NEW YORK, NY / VANCOUVER, BC (Sep 27, 2016) - Blue Mesa Health Inc., a US-based company with offices in New York and Vancouver, is pleased to announce that it has secured Series AA financing from Mobio Technologies Inc. (TSX VENTURE:MBO)(MBIOF), ("Mobio")), a Canadian-based company, with offices in Vancouver and New York.
In the past 6 months, Blue Mesa Health Inc. (“Blue Mesa”) has launched its digital Diabetes Prevention Program (“DPP”) Transform in the US enterprise payer market. The program is designed to address the problem of rising chronic disease-related health costs in the US, where one-half of all individuals are either prediabetic or diabetic. The program combines software, home health monitoring via wireless scales, Fitbit activity trackers, and remote health coaching to guide participants through a clinically validated 16-week program, the goal of which is for participants to lose approximately 5-7% of their body weight and reduce their risk of Type 2 diabetes by 58%.
"We are very pleased to have a partner like Mobio join our Series AA financing round. The executive team at Mobio has deep experience partnering with emerging ventures and they understand the enormous opportunity that Blue Mesa is addressing — preventing chronic disease is truly one of the greatest opportunities of the coming decade," said Blue Mesa Health Inc. CEO Curtis Duggan.
Blue Mesa is currently delivering a pilot program to Mount Sinai Health System, the largest hospital system (and one of the largest employers) in New York City. Blue Mesa Health is also a member of the Solera Health (“Solera”) network, which currently connects DPP providers with eligible participants in the Anthem Blue Cross network.
Mobio Technologies Inc. CEO Laurie Baggio commented on the rationale for investing in Blue Mesa Health Inc., “Current health care systems globally cannot keep up with the rising costs of treating diseases such as Type 2 diabetes. Programs like Transform help people reduce their risk of becoming ill personally, and dramatically reduce the costs to the payers in the health care system in general. We are excited to be backing great teams like Blue Mesa in pursuit of their vision.”
About Blue Mesa Health Inc.
Blue Mesa is a North American digital health company with headquarters in both New York, NY and Vancouver, BC. Blue Mesa provides a digital therapeutics program based on the CDC’s landmark National Diabetes Prevention Program. By leveraging connected hardware, wearables, the smartphone, and remote health coaching, Blue Mesa provides individuals with an effective program that significantly reduces the risk of developing Type 2 Diabetes. Employers, health plans, accountable care organizations, hospital systems and Medicare payer customers are recognizing the return on investment provided by digitally delivered preventive health programs. Prior to partnering with Mobio, Blue Mesa has raised Series AA funding from Vancouver-based firm Stanley Park Ventures Inc. and other US investors.
About Mobio Technologies Inc.
Mobio is a publicly traded company on the TSX Venture Exchange, headquartered in Vancouver, BC, and runs Strutta.com Media Inc. Strutta is a social promotions platform that helps marketers bring potential customers from stranger to fan to customer, and Strutta’s Promotions API provides a technology platform that facilitates social media competitions and campaigns for global brands. For more information visit www.mobio.net.
For press inquiries, please contact Curtis Duggan at [email protected].